Prebiotics and resistance to gastrointestinal infections
- PMID: 15877892
- DOI: 10.1079/bjn20041343
Prebiotics and resistance to gastrointestinal infections
Abstract
Acute gut disorder is a cause for significant medicinal and economic concern. Certain individual pathogens of the gut, often transmitted in food or water, have the ability to cause severe discomfort. There is a need to manage such conditions more effectively. The route of reducing the risk of intestinal infections through diet remains largely unexplored. Antibiotics are effective at inhibiting pathogens; however, these should not be prescribed in the absence of disease and therefore cannot be used prophylactically. Moreover, their indiscriminate use has reduced effectiveness. Evidence has accumulated to suggest that some of the health-promoting bacteria in the gut (probiotics) can elicit a multiplicity of inhibitory effects against pathogens. Hence, an increase in their numbers should prove effective at repressing pathogen colonisation if/when infectious agents enter the gut. As such, fortification of indigenous bifidobacteria/lactobacilli by using prebiotics should improve protection. There are a number of potential mechanisms for lactic acid bacteria to reduce intestinal infections. Firstly, metabolic endproducts such as acids excreted by these micro-organisms may lower the gut pH to levels below those at which pathogens are able to effectively compete. Also, many lactobacilli and bifidobacteria species are able to excrete natural antibiotics, which can have a broad spectrum of activity. Other mechanisms include an improved immune stimulation, competition for nutrients and blocking of pathogen adhesion sites in the gut. Many intestinal pathogens like type 1 fimbriated Escherichia coli, salmonellae and campylobacters utilise oligosaccharide receptor sites in the gut. Once established, they can then cause gastroenteritis through invasive and/or toxin forming properties. One extrapolation of the prebiotic concept is to simulate such receptor sites in the gut lumen. Hence, the pathogen is 'decoyed' into not binding at the host mucosal interface. The combined effects of prebiotics upon the lactic acid flora and anti-adhesive strategies may lead towards new dietary interventions against food safety agents.
Similar articles
-
Inulin and oligofructose: impact on intestinal diseases and disorders.Br J Nutr. 2005 Apr;93 Suppl 1:S61-5. doi: 10.1079/bjn20041345. Br J Nutr. 2005. PMID: 15877897 Review.
-
Prebiotic effects of inulin and oligofructose.Br J Nutr. 2002 May;87 Suppl 2:S193-7. doi: 10.1079/BJNBJN/2002537. Br J Nutr. 2002. PMID: 12088518 Review.
-
The role of gut-associated lymphoid tissues and mucosal defence.Br J Nutr. 2005 Apr;93 Suppl 1:S41-8. doi: 10.1079/bjn20041356. Br J Nutr. 2005. PMID: 15877894 Review.
-
Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects.J Physiol Pharmacol. 2009 Dec;60 Suppl 6:5-11. J Physiol Pharmacol. 2009. PMID: 20224145 Review.
-
Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin.J Nutr. 1999 Jul;129(7 Suppl):1438S-41S. doi: 10.1093/jn/129.7.1438S. J Nutr. 1999. PMID: 10395616 Review.
Cited by
-
Probiotics and periodontal health.J Med Life. 2011 Nov 14;4(4):387-94. Epub 2011 Nov 24. J Med Life. 2011. PMID: 22514571 Free PMC article.
-
Modulation of the Bifidobacterial Communities of the Dog Microbiota by Zeolite.Front Microbiol. 2016 Sep 22;7:1491. doi: 10.3389/fmicb.2016.01491. eCollection 2016. Front Microbiol. 2016. PMID: 27713735 Free PMC article.
-
Identification of prebiotic fructooligosaccharide metabolism in Lactobacillus plantarum WCFS1 through microarrays.Appl Environ Microbiol. 2007 Mar;73(6):1753-65. doi: 10.1128/AEM.01151-06. Epub 2007 Jan 19. Appl Environ Microbiol. 2007. PMID: 17261521 Free PMC article.
-
Protection of Galacto-Oligosaccharide against E. coli O157 Colonization through Enhancing Gut Barrier Function and Modulating Gut Microbiota.Foods. 2020 Nov 21;9(11):1710. doi: 10.3390/foods9111710. Foods. 2020. PMID: 33233359 Free PMC article.
-
Inter-species differences in the growth of bifidobacteria cultured on human milk oligosaccharides.Folia Microbiol (Praha). 2012 Jul;57(4):321-4. doi: 10.1007/s12223-012-0134-5. Epub 2012 Apr 11. Folia Microbiol (Praha). 2012. PMID: 22491988
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials